Satsuma Pharmaceuticals Company
Satsuma Pharmaceuticals is a clinical-stage biopharmaceutical company engaged in developing a novel therapeutic product.
Employee Number:
01 окт
Investors Number:
18
Funding Status:
IPO
Headquarters:
South San Francisco, California, United States
Last Funding Date:
01 03 21
Technology:
Cancer
Estimated Revenue:
$1M to $10M
Founded Date:
01 01 16
Last Funding Type:
Post-IPO Equity
Total Funding:
154000000
Industry:
Biotechnology, Health Care, Science and Engineering